An engineered Mycoplasma pneumoniae to fight Staphylococcus aureus
Bacterial infections are commonly treated with antimicrobials, but the rise of multi‐drug resistance and the presence of biofilms can compromise treatment efficacy. Recently, new approaches using live bacteria or engineered microorganisms have gained attention in the fight against several diseases....
Guardado en:
Autores principales: | Dominick Matteau, Sébastien Rodrigue |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c39d1954526f40a2b45ffde2547167a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibacterial activity of endophytic fungi in Pometia pinnata against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus
por: Ratna Setyaningsih, et al.
Publicado: (2020) -
Engineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo
por: Victoria Garrido, et al.
Publicado: (2021) -
The prevalence of Staphylococcus aureus and methicillin resistant Staphylococcus aureus in milk and dairy products in Riyadh, Saudi Arabia
por: Mashael Alghizzi, et al.
Publicado: (2021) -
Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus
por: Henrique Machado, et al.
Publicado: (2021) -
Bacteria-specific pro-photosensitizer kills multidrug-resistant Staphylococcus aureus and Pseudomonas aeruginosa
por: Min Lu, et al.
Publicado: (2021)